Navigation Links
Corbett Selected to Host the Only Midwest Global Awards Judging Competition
Date:9/4/2007

CHICAGO, Sept. 4 /PRNewswire/ -- Corbett Worldwide Healthcare Communications has been selected to host the only Midwest Global Awards Judging Event in the U.S. Robin Shapiro, Senior Vice President and Executive Creative Director for Corbett, will serve as the Host Judge. Corbett is the professional healthcare advertising business unit of the Corbett Accel Healthcare Group.

"This is a great honor," announced Elaine Eisen, President of Corbett. "The Global Awards is one of the most prestigious award programs in our industry."

The Global Awards honor the best in worldwide healthcare communications. Now in their 13th year, The Global Awards are recognized as the only awards program dedicated to healthcare communications on an international basis. Categories in The Global Awards extend over regional, national and continental boundaries. Participation in this year's Global Awards has come from more than 39 countries worldwide.

"The Global Awards set the industry standard for creative and marketing excellence around the world," noted Robin Shapiro, Executive Creative Director of Corbett. "I believe we should hold our creative ideas to international standards; some of the most surprising and compelling ideas in our industry come from outside the U.S."

The Midwest is recognized as a destination for clients seeking outstanding creative in the pharmaceutical space. "We believe this is due in large part to a unique, non-recycled talent pool," commented Eisen. "At Corbett, we take our approach to talent recruitment and development one step further by combining proven consumer and pharmaceutical brand builders. This healthy collision of talent results in very fresh ideas that change behavior and move market share."

The preliminary judging will occur Wednesday, September 5, 2007 at the Corbett offices in Chicago. Winning entries in this event will move on to be judged as finalists in New York City. For more information on The Global Awards and
'/>"/>

SOURCE Corbett Worldwide Healthcare Communications
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Hospital Selected to ‘25 Most Influential’ List in Radiology in 206
2. Six Towns in India Selected for Eco-City Project
3. Invasion of Cicada Hordes Feared in US Midwest
4. Dementia - a global problem
5. First global SARS meet opens
6. Obesity a global problem
7. Suggestions to reduce global heart disease burden
8. Drop in global deaths from measles
9. SARS-Free Taiwan to Mark End Phase of Global Fight
10. Prevent Global Warming by Becoming A Vegetarian
11. India To March Ahead in The Global HealthCare Competition

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ould lead mothers to overlook needed care, study f...ews) -- A mother,s depression can worsen her child... six-month study of 262 black mothers and their ch...depressive symptoms had more frequent asthma sympt...ve symptoms had less frequent asthma symptoms. ,...
(Date:11/25/2009)...RNewswire/-- MISSIONSkincare ®isproudtosuppor...partofGNC,sannualSt.Jude ThanksandGiving campaign,...ew SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addi...5or$10donationatcheckoutatoneoftheir5,000+retaillo...nforSt.Judeduringtheir2009 ThanksandGiving campaig...
(Date:11/25/2009)...cancer vaccine carried into the body on a carefull...t to successfully eliminate tumors in mammals, sci...ranslational Medicine . , The new approach, pion... University, uses plastic disks impregnated with t...n to reprogram the mammalian immune system to atta...
(Date:11/25/2009)...der the skin kill tumor cells, study finds , ...ncer vaccine delivered in a fingernail-size implan...reports. , The method uses polymer disks, 8.5 m...-specific antigens and implanted under the skin to... Harvard University scientists who developed the i...
(Date:11/25/2009)... Initiative expands to include cost-effective, su..., and healthcare professionals in developing world...) November 25, 2009 -- Elluminate, Inc. , the lea...lutions that support 21st century teaching, learn...Fire and Ice initiative was awarded iNACOL,s fir...
Breaking Medicine News(10 mins):Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
... today announced the acquisition of Taylor Benefit...on were not disclosed., Established in 1996, Tayl...t consultation and brokerage services for their We...ngs accounts, health,reimbursement arrangements an...
...Feb. 18 The following is being,issued by the Chic...iety (CDS) recently polled more than 300,dentists ...ts seeking,braces, and how the current presidentia...are a few of the leading,tips for expectant mother...
...ralia,(MLA) has selected IMTEC Corporation to deve...stock carcasses. Using IMTEC,s 3D imaging,technolo...se 1 of a,multi-year, 6 phase process for objectiv...d other quality attributes., "IMTEC is very excit...
...tional organization formed to halt the US governme... holding a press conference in Wichita, Kansas,out...papers asking for an,emergency order to protect Ka...mplet ,e.zip, Siobhan Reynolds, President of the ...
...ht, scientists from the National Institute of Stan...o at Boulder have shown that they can detect molec...or cancer. , While the new technique has yet to b...arch team from JILA, a joint institute of NIST and...
...s, Inc. (Nasdaq: ONXX ) today announced that it w...ovide an update on Nexavar(R),(sorafenib) tablets,...r,2007 financial results, on Tuesday, February 19,...ial results for the,fourth quarter and year ended ...
Other Medicine News:Health News:Dentists' Top Five Oral Health Care Tips During Pregnancy 2Health News:IMTEC to Become Technology Solutions Provider for Meat & Livestock Australia 2Health News:Pain Relief Network Sues to Halt Government Actions Taken Against Kansas Patients 2Health News:Scientists using laser light to detect potential diseases via breath samples, says new study 2Health News:Scientists using laser light to detect potential diseases via breath samples, says new study 3Health News:Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled 2
(Date:11/24/2009)... ,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WH...r23yearsfollowinganautoaccident,wasactuallyfullyco...odMorningAmericasegment.TheDynaVoxEyeMaxwasfeature...dromeandotherconditionscanunlockcommunication. ,...ailableonlineat www.dynavoxtech.com ,, W...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--A...odaythatitwillpresentatthe21stAnnualPiperJaffrayHe...m.EST(6:00a.m.PST).TheconferenceisbeingheldatTheNe...iefExecutiveOfficerofAnadys,willprovideanoverviewo...ANA773. ,, Thecorporatepresentationwillbesimult...
(Date:11/24/2009)... ,, SANDIEGO,Nov.24/PRNewswire/--Accumetrics...fyNow®System,thefirstrapidandeasy-to-usediagn...tipleantiplateletagents(e.g.Plavix®andaspirin...ofAccumetrics,andGregoryJ.Tibbitts,ChiefFinancialO...viewatthe21stAnnualPiperJaffrayHealthCareConferenc...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 1Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 2Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 3Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 47727 4Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 1Sound Surgical Technologies Chief Technology Officer Presents Paper on Focused Ultrasound Technology 47724 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 1China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 2China Sky One Medical Inc Obtains SFDA Approval for Diclofenac Sodium Eye Drops 47721 3
...ial Expected to Initiate in 2010 for Blinatumomab ... MITI ), a biopharmaceutical company developing no...ancer, inflammation and autoimmune diseases, today...nalysts at The Yale Club of New York City. , , ... development across Micromet,s BiTE antibody platf...
... Presented Today at 44th Annual Meeting of EASL , ... Status During Q1 Financial Results Call at 5 P.M....aceuticals, Inc. (Nasdaq: ANDS ) today announced...cleoside polymerase inhibitor, demonstrated potent...l tolerated in a Phase Ib study in which patients ...
Other Medicine Technology:Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 2ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 3ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 4ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 5ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 6ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 7ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients 8
Pure Eyes
Graether Collar Button
Lobob Hard Lens Soaking Solutions
Crawford Fascia Stripper
Medicine Products: